Anjarium Biosciences Funding: $60M Raised, Series A (2021)
Anjarium Biosciences is based in Schlieren, Switzerland. It has raised $60M in total funding. Latest round: Series A.
Anjarium Biosciences funding overview
Anjarium Biosciences is based in Schlieren, Switzerland. Anjarium Biosciences has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Anjarium Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Abingworth, Gimv, Pfizer Ventures, Surveyor Capital, Omega Funds, Sofinnova Investments. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Anjarium Biosciences funding
How much has Anjarium Biosciences raised?
Anjarium Biosciences has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Anjarium Biosciences?
Abingworth, Gimv, Pfizer Ventures, Surveyor Capital, Omega Funds, Sofinnova Investments are named among the investors backing Anjarium Biosciences.
What was the latest Anjarium Biosciences funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is Anjarium Biosciences based?
Anjarium Biosciences is based in Schlieren, Switzerland.
When did Anjarium Biosciences last raise?
The last disclosed Anjarium Biosciences round closed in September 2021 at Series A.
Round data for Anjarium Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Schlieren and backer lists below.
